Stryker (SYK) Change in Accured Expenses (2009 - 2026)
Stryker (SYK) posted quarterly Change in Accured Expenses of $298.0 million for Q2 2026, down 23.2% year-over-year from $388.0 million in Q2 2025, and up 145.57% on a QoQ basis from -$654.0 million in Q1 2026.
Stryker (SYK) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Stryker has reported Change in Accured Expenses for 18 years, with the latest figure at $298.0 million in Q2 2026.
- Change in Accured Expenses for Q2 2026 came in at $298.0 million, down 23.2% year-over-year; the trailing twelve-month figure through Jun 2026 was $78.0 million (down 87.23% YoY), and the FY2025 annual result was $318.0 million, up 329.73% from the prior year.
- Change in Accured Expenses climbed to $298.0 million in Q2 2026, from -$654.0 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $429.0 million in Q3 2024 and troughed at -$654.0 million in Q1 2026.
- A 5-year average of $39.3 million and a median of $195.5 million in 2022 frame the typical range for Change in Accured Expenses.
- The widest annual swing landed in 2024, when Change in Accured Expenses plunged 107.5%; it then soared 2255.56% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at $151.0 million in 2022, then jumped by 143.05% to $367.0 million in 2023, then declined by 18.8% to $298.0 million in 2024, then jumped by 32.89% to $396.0 million in 2025, then retreated by 24.75% to $298.0 million in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were $298.0 million in Q2 2026, -$654.0 million in Q1 2026, and $396.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.20 Bn | 18.79 Bn | 1.54 Bn | 92.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 298.00 Mn |
| Jun 30, 2026 | 298.00 Mn |
| Mar 31, 2026 | -654.00 Mn |
| Mar 31, 2026 | -654.00 Mn |
| Dec 31, 2025 | 396.00 Mn |
| Dec 31, 2025 | 396.00 Mn |
| Sep 30, 2025 | 38.00 Mn |
| Sep 30, 2025 | 38.00 Mn |
| Jun 30, 2025 | 388.00 Mn |
| Jun 30, 2025 | 388.00 Mn |
| Mar 31, 2025 | -504.00 Mn |
| Mar 31, 2025 | -504.00 Mn |
| Dec 31, 2024 | 298.00 Mn |
| Dec 31, 2024 | 298.00 Mn |
| Sep 30, 2024 | 429.00 Mn |
| Sep 30, 2024 | 429.00 Mn |
| Jun 30, 2024 | -18.00 Mn |
| Jun 30, 2024 | -18.00 Mn |
| Mar 31, 2024 | -635.00 Mn |
| Mar 31, 2024 | -635.00 Mn |